AXQ Capital’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

AXQ Capital’s Portfolio NBP Stock Details NBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$205K	Buy	+83,330	New	+$279K	0.03%	739

Other funds holding NBP

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

ACM

AIHC Capital Management Central $120M AUM

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AXQ Capital's NBP Position: Q1 2026 in Review

AXQ Capital opened a new position in NovaBridge Biosciences American Depositary Shares (NBP) in Q1 2026: 83,330 shares worth $205K. The stake represents 0.03% of the portfolio and ranks #739 among its holdings.

48 funds tracked by Wall St. Rank hold NBP as of Q1 2026.

AXQ Capital held 83,330 shares of NovaBridge Biosciences American Depositary Shares worth $205K as of Q1 2026.
NovaBridge Biosciences American Depositary Shares was a new AXQ Capital position in Q1 2026.
NovaBridge Biosciences American Depositary Shares made up 0.03% of AXQ Capital's portfolio in Q1 2026, its #739 holding.
48 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q1 2026.

Based on AXQ Capital's 13F filing for Q1 2026, filed 13 May 2026.